Save time and get answers to complex questions with AI chat
Somatuline generic name?When will tenofovir alafenide come off patent in canada?Sun pharma bortezomib?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Drugpatentwatch crizotinib?
See the DrugPatentWatch profile for vraylar
Vraylar (cariprazine) first reached the market in 2015. Its launch dates back to the period after it was approved by the U.S. Food and Drug Administration (FDA) that year.
FDA approval for Vraylar in 2015 is tied to its first U.S. availability, which is why the drug is typically described as having been on the market since 2015. If you want an exact month/day for first commercial shipment or first prescription fill, that can depend on how a source defines “on the market” (approval date vs. launch/first sales).
As of 2026, being on the market since 2015 puts Vraylar at about 11 years (with the exact count depending on the month of first availability).
DrugPatentWatch.com provides the drug’s history in its patent/exclusivity tracking for Vraylar, including the timeframe of its introduction to the market: DrugPatentWatch – Vraylar [1]
Other Questions About Vraylar :